Return to the home page of the Diabetes Monitor
diabetes news for October 2007
Advertisement



 
go to home page read about us contact us read our disclaimer go to the index read our mission statement read our privacy policy search our website go to the site map find out what's new

    • October 27, 2007    It may be possible for people with type 2 diabetes to reverse a heart threat (silent myocardial ischemia) without surgery, a new study shows. The researchers expected that the patients' ischemia would have worsened over 3 years. But of the 71 patients who had ischemia at the study's start, 56 patients (79%) no longer had ischemia three years later. That finding was "striking and unexpected", the authors write. Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study Diabetes Care 2007 30: 2892-2898. [Story at WebMD: Abstract at D Care; full text at D Care, requires subscription.]
      
      
      Advertisement
      
      
      
      
      Advertisement
      
      

    • October 18, 2007    In a statement at their website, Pfizer has announced they are discontinuing the sale of their inhaled insulin product, Exubera: "we made an important decision regarding Exubera, a product for which we initially had high expectations," said Jeff Kindler, Chairman and Chief Executive Officer. "Despite our best efforts, Exubera has failed to gain the acceptance of patients and physicians. We have therefore concluded that further investment in this product is unwarranted." [Pfizer Reports Third-Quarter 2007 Results.]

    • October 17, 2007    The FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta, a drug used to treat adults with type 2 diabetes. An association between Byetta and acute pancreatitis is suspected in some of these cases. Healthcare professionals should instruct patients taking Byetta to seek prompt medical care if they experience unexplained persistent severe abdominal pain which may or may not be accompanied by vomiting. If pancreatitis is suspected, Byetta should be discontinued. If pancreatitis is confirmed, Byetta should not be restarted unless an alternative etiology is identified. [FDA announcement at Exenatide (marketed as Byetta) Information.]

    • October 13, 2007    Actress Aida Turturro, who played Tony Soprano's sister in the HBO series "The Sopranos," is nothing if not passionate. Her passion for acting is apparent in the numerous roles she has played on stage and film, becoming famous for her portrayal of Tony Soprano's sister, Janice, in "The Sopranos." But Turturro, 45, is just as passionate about controlling her type 2 diabetes and helping others learn how to manage theirs -- taking time when she can to tour and talk about how she came to terms with the disease and the lifestyle changes she needed to make to address it. [Story at ScrippsNews: Actress encourages others to deal with diabetes.]

    • October 4, 2007    The Nursing Online Education Database has announced its listing of the Top 100 Health and Wellness Blogs. "These top blogs were chosen for their popularity among users as well as their successes - both as professionals and as individuals who have changed or who are publicly changing lifestyles and overcoming their diseases and disabilities." Two websites that I have authored, Diabetes.Blog.com and my comments at MyDiabetesCentral.com, were among those selected for inclusion in the list. The complete listing is available at the NOEDb website: click here. Bill the DiabetesDoc.

    • October 1, 2007    Cuba has 375,000 diagnosed diabetics under treatment, that is, 3.3% of the population. But the current trend indicates the figure has doubled for the past 20 years. [Story at CubaHeadlines.com: Sweet epidemic, how sweet it isn't.]




Advertisements





Google Ads


  [Top]   Last month's diabetes news  
Advertisement
 

Return to the home page of the Diabetes Monitor Go to the index Search this website Go to the site map Read our copyright noticeRead our copyright notice Send us an e-mail at info@diabetesmonitor.com